(10 000/mm3) with 78 % As legionnaires' disease was suspected on admission he was given erythromycin 500 mg four times daily for 10 days. The abscess of the
appendix was treated conservatively with intravenous fluids, and gentamicin and metronidazole were given for 10 days. On this regimen his condition improved steadily, the pneumonia having cleared clinically and radiologically after 12 days in hospital. Appendicectomy was performed two months later. Histological examination showed a subacute abscess with no specific features. He has remained asymptomatic since the operation.
Comment
Although abdominal symptoms are often present in patients with legionnaires' disease, structural lesions of the gastrointestinal tract have not been found at necropsy. The symptoms of appendicitis were this patient's main complaint-in fact, despite extensive pneumonia, he complained of a dry cough only on direct questioning. While this may have been a chance association, I believe that this complication might be overlooked in a patient severely ill with respiratory failure or encephalopathy, and if not treated correctly might have a deleterious effect on the outcome. Spacing between doses on a thrice-daily regimen
The effect of drug treatment is related not only to the number of doses taken but also to the timing of doses. This is particularly true for drugs with a narrow therapeutic range and a short elimination half-life. While considerable variations in the patients' interpretations of the prescription label have been reported,' the spacing between doses has not been studied objectively. We used a recording medication monitor2 to study the spacing between doses by patients on a thrice-daily regimen and to study the validity of interview data on the timing of doses.
Patients, methods, and results
The medication behaviour of 82 patients (45 men, 37 women) aged 56-90 years who were being treated with pilocarpine thrice daily for simple glaucoma was studied for three weeks with a medication monitor, which recorded the date and hour each time the medication bottle was opened.2 Other sources of the drug were controlled, and the patients were not told that their drug-taking was being monitored until all the data had been collected.
Intervals between doses of pilocarpine prescribed three times daily After the recording period the patients were asked at which hours of the day they usually took the drug. Five patients were lost from these interviews. Comparisons with data from the monitor showed good agreement: for 85 % of the intervals the difference was one hour or less. Only nine patients reported an interval with a deviation of more than two hours from that recorded by the monitor.
Comment
Although interview data on missed doses are often inaccurate,3 our findings show that interviews with patients were accurate in determining the spacing between doses. In studies of medication compliance data on the spacing between doses gained at interview may be combined with other methods to determine the number of doses takenfor example, pill count. In routine medical practice interviews may be useful for obtaining information about irregular dosage intervals and as a first step towards improving the situation.
A striking finding was the irregular timing of doses among patients on a thrice-daily regimen. Assuming that the effective duration of the drug is about eight hours,4 it is probable that long night intervals unfavourably influence the result of the treatment. Among patients with a twice-daily regimen Hermann found a tendency to spread doses more regularly, with an average night interval of 13 6 hours.' There is evidence that the proportion of missed doses is lower with a twice-daily than with a thrice-daily regimen.5
Hence, both in terms of missed doses and of spacing between doses, drugs prescribed twice daily will probably be more properly administered than those prescribed three times a day. When it is not possible to reduce the frequency of doses tailoring of doses to daily routines may improve compliance both in terms of spacing and of missed doses.5 scein technique designed to study medication behaviour. Acta Ophthalmol(Copenh) 1980; 58:459-67 
